TABLE 3.
Significant prognostic factors for overall survival of group B patients
| Univariable analysis | Multivariable analysis | |||||
|---|---|---|---|---|---|---|
| HR | 95 % CI | P value | HR | 95 % CI | P value | |
| Age >60 years | 1.06 | (0.82–1.38) | 0.63 | |||
| Male gender | 1.07 | (0.83–1.39) | 0.59 | |||
| No. of lesions >3 | 1.7 | (1.22–2.37) | <0.001 | 1.56 | (1.09–2.23) | 0.02 |
| Cirrhosis | 1.24 | (0.79–1.95) | 0.34 | |||
| Vascular invasion | 1.31 | (1.00–1.72) | 0.05 | |||
| Perineural invasion | 0.88 | (0.61–1.27) | 0.49 | |||
| Biliary invasion | 1.41 | (0.99–2.01) | 0.05 | |||
| Direct invasion of contiguous organs | 1.39 | (0.95–2.03) | 0.09 | |||
| Nodal metastasis | 1.71 | (1.25–2.34) | <0.001 | 1.47 | (1.05–2.07) | 0.02 |
| Poor tumor differentiation | 1.53 | (1.16–2.02) | <0.001 | 1.48 | (1.11–1.96) | 0.01 |
| Major hepatectomy | 1.05 | (0.79–1.41) | 0.73 | |||
| R1 margins | 1.29 | (0.90–1.85) | 0.16 | |||
| No. lymphadenectomy | 1.07 | (0.83–1.39) | 0.60 | |||
| No. of lymph node harvested <3 | 0.85 | (0.60–1.21) | 0.36 | |||
HR hazard ratio, CI confidence interval.